NO923548L - Hsv gd2 baculovirus-ekspresjonssystem - Google Patents

Hsv gd2 baculovirus-ekspresjonssystem

Info

Publication number
NO923548L
NO923548L NO92923548A NO923548A NO923548L NO 923548 L NO923548 L NO 923548L NO 92923548 A NO92923548 A NO 92923548A NO 923548 A NO923548 A NO 923548A NO 923548 L NO923548 L NO 923548L
Authority
NO
Norway
Prior art keywords
expression system
baculovirus expression
hsv
recombinant
glycoprotein formed
Prior art date
Application number
NO92923548A
Other languages
English (en)
Norwegian (no)
Other versions
NO923548D0 (no
Inventor
Victoria Ann Landolfi
Natalie Beth Figueroa
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO923548D0 publication Critical patent/NO923548D0/no
Publication of NO923548L publication Critical patent/NO923548L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92923548A 1991-09-13 1992-09-11 Hsv gd2 baculovirus-ekspresjonssystem NO923548L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75931091A 1991-09-13 1991-09-13

Publications (2)

Publication Number Publication Date
NO923548D0 NO923548D0 (no) 1992-09-11
NO923548L true NO923548L (no) 1993-03-15

Family

ID=25055183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923548A NO923548L (no) 1991-09-13 1992-09-11 Hsv gd2 baculovirus-ekspresjonssystem

Country Status (8)

Country Link
EP (1) EP0531728A1 (fr)
JP (1) JPH05252965A (fr)
AU (1) AU2355392A (fr)
CA (1) CA2078087A1 (fr)
FI (1) FI924080A (fr)
IL (1) IL103130A0 (fr)
NO (1) NO923548L (fr)
TW (1) TW232710B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017938A1 (fr) * 1994-12-06 1996-06-13 Bruschettini S.R.L. Glycoproteines provenant de l'herpesvirus et vaccins contenant celles-ci
KR100408817B1 (ko) * 1995-07-28 2004-02-25 주식회사 엘지생명과학 헤르페스심플렉스바이러스의당단백질을대량발현시키는동물세포주
US6821519B2 (en) 2000-06-29 2004-11-23 Corixa Corporation Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
ATE349533T1 (de) 2000-06-29 2007-01-15 Corixa Corp Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE494907T1 (de) 2002-07-18 2011-01-15 Univ Washington Pharmazeutische zusammensetzungen, die immunologisch aktive herpes simplex virus proteinfragmente enthalten
EP1690937B1 (fr) 2003-11-04 2012-10-17 Dnavec Research Inc. Methode de construction d'une cellule dendritique transgenique
US8741639B2 (en) 2008-11-14 2014-06-03 Dnavec Corporation Method for producing dendritic cells

Also Published As

Publication number Publication date
NO923548D0 (no) 1992-09-11
JPH05252965A (ja) 1993-10-05
IL103130A0 (en) 1993-02-21
TW232710B (fr) 1994-10-21
AU2355392A (en) 1993-03-18
EP0531728A1 (fr) 1993-03-17
FI924080A0 (fi) 1992-09-11
CA2078087A1 (fr) 1993-03-14
FI924080A (fi) 1993-03-14

Similar Documents

Publication Publication Date Title
MY110086A (en) Herpes simplex virus vaccines comrpising glycoprotein d and 3d-mpl
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
WO1997049373A3 (fr) Traitement et prevention de l'infection par le vih par l'administration de derives de la gonadotrophine chorionique humaine
FI862011A0 (fi) Terapeutiska nukleosider.
DK77090A (da) Immunmodulerende azaspiraner
EP0541692A4 (en) Herpes simplex virus vp16 vaccines
NO931133D0 (no) Legemidler av polyhydroksymetylenderivater, fremgangsmaater for deres fremstilling og anvendelse
HK107595A (en) Recombinant herpes simplex gb-gd vaccine
NO923548L (no) Hsv gd2 baculovirus-ekspresjonssystem
HUP9801266A2 (hu) Multimer, rekombináns ureázvakcina
ZA885577B (en) A pharmaceutical combination product and the preparation and use thereof
EP0289550A4 (fr) Vaccin utilise pour le traitement therapeutique de hsv.
NZ235316A (en) Vaccine containing capsular polysaccharide conjugated to recombinant c protein of a group b streptococcus, production and use against b streptococcus infection
DE69527294D1 (en) 4-[2-amino-6-(cyclopropylamino)-9h-pyrin-9-yl]-2-cyclopenten-1-methanol-succinat als antivirales mittel
NO974561L (no) Chlamydia-vaksine
AU6383296A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
EP0560776A4 (en) The gene encoding equine herpesvirus type 1 glycoprotein d, its gene product, antibodies and their uses
GR3005736T3 (fr)
AU5061090A (en) Aids therapy
NO179855C (no) Fremgangsmåte for fremstilling av et legemiddel
NZ256246A (en) Serine leukocyte protease inhibitor, recombinant preparation thereof, and treatment of a retroviral infection
MY111746A (en) Therapeutic nucleosides.
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.
NO872331L (no) Farmasoeytiske preparater for behandling av bakterielle infeksjoner.
WO1988008707A3 (fr) Derives de rubradirine pour le traitement de l'infection hiv